Profund Advisors’s Cidara Therapeutics CDTX Stock Holding History

Profund Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,931	Closed	-$2.19M	–	1131
2025 Q4	$2.19M	Buy	9,931 +3,156	+47%	+$510K	0.07%	200
2025 Q3	$649K	Buy	+6,775	New	+$432K	0.02%	437

Profund Advisors's CDTX Position: Q1 2026 in Review

Profund Advisors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 9,931 shares — an estimated $2.19M sold.

Profund Advisors first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $2.19M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Profund Advisors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Profund Advisors sold 9,931 Cidara Therapeutics shares in Q1 2026, an estimated $2.19M.
Profund Advisors first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Profund Advisors's Cidara Therapeutics position peaked at $2.19M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.